Autonomous AI Revolutionizes Cancer Detection

The “Autonomous AI for Cancer Detection” project, a major collaboration between ScreenPoint Medical, Radboud University Medical Center (RUMC) and Thirona, is set to transform the landscape of cancer detection from 2025 to 2028. Supported by the European Fund for Regional Development (ERDF), the project aims to integrate autonomous AI into medical imaging to accelerate early cancer detection while reducing the intense workload on healthcare professionals.

One of the key technical pillars of the project is Thirona’s development of automated bronchoscope route planning for lung biopsies. This innovation aim to save physicians roughly 20 minutes per case and increase the diagnostic yield of lung cancer biopsies by 20% on average. Collectively, these advancements target an increase in patient survival rates by catching cancer in its earliest, most treatable stages, while significantly lowering healthcare costs through more efficient hospital workflows.

Structural Insights in Severe Asthma Paving the Way for More Precise Treatment Stratification

Redefining Bronchiectasis Trials Through AI-Powered Image Analysis

Thirona Receives FDA Clearance for LungQ® 4 Software, Expanding AI-Powered Capabilities in Lung Image Analysis for the U.S. Market

Thirona and VIDA Diagnostics Partner to Accelerate Respiratory Clinical Trials with Advanced AI Imaging

Comprehensive assessment of mucus impaction with Artificial Intelligence

Artificial Intelligence detects substantial airway damage on CT scans of children with severe asthma

Do you want to stay up to date with our new developments?